Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection

首次发布于 2014 年 9 月 16 日

Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours

计划入组 83 人 · 首次发布于 2008 年 12 月 17 日

Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2

计划入组 68 人 · 首次发布于 2011 年 6 月 1 日

D-Alanine

C₃H₇NO₂

Vitamin D(Mvc-fluoride, Vitafol-one)

Rx

D-797 + D-324

Shilpa Medicare Ltd.

India

EDOGAWA MEDICARE HOSPITAL

Japan

SHILPA MEDICARE LIMITED

India

Medicare Part D Expands MTM Services to Include HIV/AIDS Coverage in 2025

Medicare Part D Protected Classes See 58% Initial Rejection Rate Despite Coverage Protections

Major Insurers and PBMs Control 34% of Medicare Part D Pharmacy Spending, Study Reveals